Most current prenatal testing approaches like amniocentesis or chorionic villus sample include a certain degree of risk of miscarriage, but cell-free DNA testing relies on a blood sample, potentially changing what disorders can be looked for, Erin Biba at Wired writes. "Based on a small sample of a woman's blood, the cell-free fetal DNA test gives expectant mothers an earlier (and safer) look than ever at just who it is that's growing inside them," she adds.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.